Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade

被引:0
|
作者
Rebecca L Pratt
Michael S Kinch
机构
[1] Purdue University Cancer Center,Department of Basic Medical Sciences
[2] MedImmune,undefined
[3] Inc.,undefined
来源
Oncogene | 2002年 / 21卷
关键词
Eph kinase; Eck; signal transduction;
D O I
暂无
中图分类号
学科分类号
摘要
Intracellular signaling by receptor tyrosine kinases regulates many different aspects of cell behavior. Recent studies in our laboratory and others have demonstrated that the EphA2 receptor tyrosine kinase critically regulates tumor cell growth, migration and invasiveness. Although the cellular consequences of EphA2 signaling have been the focus of recent attention, the biochemical changes that are triggered by ligand-mediated activation of EphA2 remain largely unknown. Herein, we demonstrate that ligand stimulation of EphA2 promotes the nucleus translocation and phosphorylation of ERK kinases, followed by an increase in nuclear induction of the Elk-1 transcription factor. Ligand-mediated activation allows EphA2 to form a molecular complex with the SHC and GRB2 adaptor proteins. Specifically, we demonstrate that tyrosine phosphorylated EphA2 interacts with the PTB and SH2 domains of SHC. We also show that the interaction of EphA2 with GRB2 is indirect and mediated by SHC and that this complex is necessary for EphA2-mediated activation of ERK kinases. These studies provide a novel mechanism to demonstrate how EphA2 can convey information from the cell exterior to the nucleus.
引用
收藏
页码:7690 / 7699
页数:9
相关论文
共 50 条
  • [1] Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade
    Pratt, RL
    Kinch, MS
    ONCOGENE, 2002, 21 (50) : 7690 - 7699
  • [2] Activation of the EphA2 receptor tyrosine kinase by a conditional transmembrane peptide
    Barrera, Francisco
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [3] Functional Oligomerization of the EphA2 Receptor Tyrosine Kinase
    Shi, Xiaojun
    Lingrak, Ryan
    Cuizon, Carmelle
    Toth, Paul
    Zheng, Ji
    Smith, Adam
    Wang, Bingcheng
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 97A - 97A
  • [4] Overexpression of the EphA2 tyrosine kinase in prostate cancer
    Walker-Daniels, J
    Coffman, K
    Azimi, M
    Rhim, JS
    Bostwick, DG
    Snyder, P
    Kerns, BJ
    Waters, DJ
    Kinch, MS
    PROSTATE, 1999, 41 (04): : 275 - 280
  • [5] The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
    Zapata-Mercado, Elmer
    Biener, Gabriel
    McKenzie, Daniel M.
    Wimley, William C.
    Pasquale, Elena B.
    Raicu, Valerica
    Hristova, Kalina
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (10)
  • [6] Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade
    Avruch, J
    Khokhlatchev, A
    Kyriakis, JM
    Luo, ZJ
    Tzivion, G
    Vavvas, D
    Zhang, XF
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 127 - 155
  • [7] Progranulin and the receptor tyrosine kinase EphA2, partners in crime?
    Chitramuthu, Babykumari
    Bateman, Andrew
    JOURNAL OF CELL BIOLOGY, 2016, 215 (05): : 603 - 605
  • [8] THE TYROSINE KINASE RECEPTOR EPHA2 IS A DRUG TARGET FOR OSTEOARTHRITIS
    Ferrao Blanco, M. N.
    Bastiaansen-Jenniskens, Y. M.
    Narcisi, R.
    Chambers, M. G.
    Pitsillides, A. A.
    van Osch, G. J.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S36 - S37
  • [9] Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
    Kinch, MS
    Carles-Kinch, K
    CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (01) : 59 - 68
  • [10] Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
    Michael S. Kinch
    Kelly Carles-Kinch
    Clinical & Experimental Metastasis, 2003, 20 : 59 - 68